These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 21139151

  • 61. The future of HIV microbicides: challenges and opportunities.
    Garg AB, Nuttall J, Romano J.
    Antivir Chem Chemother; 2009; 19(4):143-50. PubMed ID: 19374141
    [Abstract] [Full Text] [Related]

  • 62. A randomized, double-blind, placebo-controlled safety and acceptability study of two Invisible Condom formulations in women from Cameroon.
    Mbopi-Keou FX, Trottier S, Omar RF, Nkele NN, Fokoua S, Mbu ER, Giguere JF, Domingo MC, Piret J, Tsague L, Zekeng L, Mwatha A, Mâsse B, Bergeron MG.
    Contraception; 2009 Nov; 80(5):484-92. PubMed ID: 19835725
    [Abstract] [Full Text] [Related]

  • 63. The safety, persistence, and acceptability of an antiretroviral microbicide candidate UC781.
    Bunge K, Macio I, Meyn L, Noguchi L, Parniak MA, Schwartz JL, Moncla B, Hillier S.
    J Acquir Immune Defic Syndr; 2012 Aug 01; 60(4):337-43. PubMed ID: 22495787
    [Abstract] [Full Text] [Related]

  • 64. A Randomized Crossover Study Evaluating the Use and Acceptability of the SILCS Diaphragm Compared to Vaginal Applicators for Vaginal Gel Delivery.
    Beksinska M, Greener R, Smit J, Maphumulo B, Mphili N, Kilbourne-Brook M, Coffey PS.
    AIDS Behav; 2018 Jan 01; 22(1):127-132. PubMed ID: 28993940
    [Abstract] [Full Text] [Related]

  • 65. Preferred Physical Characteristics of Vaginal Film Microbicides for HIV Prevention in Pittsburgh Women.
    Fan MD, Kramzer LF, Hillier SL, Chang JC, Meyn LA, Rohan LC.
    Arch Sex Behav; 2017 May 01; 46(4):1111-1119. PubMed ID: 27571742
    [Abstract] [Full Text] [Related]

  • 66. Development and in vitro evaluation of a vaginal microbicide gel formulation for UAMC01398, a novel diaryltriazine NNRTI against HIV-1.
    Grammen C, Ariën KK, Venkatraj M, Joossens J, Van der Veken P, Heeres J, Lewi PJ, Haenen S, Augustyns K, Vanham G, Augustijns P, Brouwers J.
    Antiviral Res; 2014 Jan 01; 101():113-21. PubMed ID: 24269474
    [Abstract] [Full Text] [Related]

  • 67. Transport theory for HIV diffusion through in vivo distributions of topical microbicide gels.
    Lai BE, Henderson MH, Peters JJ, Walmer DK, Katz DF.
    Biophys J; 2009 Nov 04; 97(9):2379-87. PubMed ID: 19883580
    [Abstract] [Full Text] [Related]

  • 68. Predictors of adherent use of diaphragms and microbicide gel in a four-arm, randomized pilot study among female sex workers in Madagascar.
    Turner AN, Van Damme K, Jamieson DJ, Khan MR, Pettifor AE, Swezey TA, Bell AJ, Newman DR, Penman-Aguilar A, Raharinivo MS, Randrianasolo B, Ramiandrisoa FN, Behets FM, Mad STI Prevention Group.
    Sex Transm Dis; 2009 Apr 04; 36(4):249-57. PubMed ID: 19265745
    [Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70. Women's preferences for vaginal antimicrobial contraceptives. V: attitudes of Brazilian women to the insertion of vaginal products.
    Hardy E, de Pádua KS, Hebling EM, Osis MJ, Zaneveld LJ.
    Contraception; 2003 May 04; 67(5):391-5. PubMed ID: 12742563
    [Abstract] [Full Text] [Related]

  • 71. Clinical development of microbicides for the prevention of HIV infection.
    D'Cruz OJ, Uckun FM.
    Curr Pharm Des; 2004 May 04; 10(3):315-36. PubMed ID: 14754390
    [Abstract] [Full Text] [Related]

  • 72. Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial: a mixed-methods study.
    Rosen RK, Morrow KM, Carballo-Diéguez A, Mantell JE, Hoffman S, Gai F, Maslankowski L, El-Sadr WM, Mayer KH.
    J Womens Health (Larchmt); 2008 Apr 04; 17(3):383-92. PubMed ID: 18328009
    [Abstract] [Full Text] [Related]

  • 73. Erosion of microbicide formulation coating layers: effects of contact and shearing with vaginal fluid or semen.
    Geonnotti AR, Peters JJ, Katz DF.
    J Pharm Sci; 2005 Aug 04; 94(8):1705-12. PubMed ID: 15986472
    [Abstract] [Full Text] [Related]

  • 74. Microbicide acceptability among high-risk urban U.S. women: experiences and perceptions of sexually transmitted HIV prevention.
    Weeks MR, Mosack KE, Abbott M, Sylla LN, Valdes B, Prince M.
    Sex Transm Dis; 2004 Nov 04; 31(11):682-90. PubMed ID: 15502677
    [Abstract] [Full Text] [Related]

  • 75. Increasing the effectiveness of vaginal microbicides: a biophysical framework to rethink behavioral acceptability.
    Verguet S, Young Holt B, Szeri AJ.
    PLoS One; 2010 Nov 22; 5(11):e15501. PubMed ID: 21124931
    [Abstract] [Full Text] [Related]

  • 76. Acceptability of and Adherence to an Antiretroviral-Based Vaginal Microbicide among Pregnant Women in the United States.
    Montgomery ET, Noguchi LM, Dai JY, Pan J, Biggio J, Hendrix C, Isaacs K, Watts DH, Schwartz JL, Piper J, Beigi R.
    AIDS Behav; 2018 Feb 22; 22(2):402-411. PubMed ID: 28550377
    [Abstract] [Full Text] [Related]

  • 77. New candidate biomarkers in the female genital tract to evaluate microbicide toxicity.
    Fields S, Song B, Rasoul B, Fong J, Works MG, Shew K, Yiu Y, Mirsalis J, D'Andrea A.
    PLoS One; 2014 Feb 22; 9(10):e110980. PubMed ID: 25333937
    [Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79. Safety and tolerability of vaginal PRO 2000 gel in sexually active HIV-uninfected and abstinent HIV-infected women.
    Mayer KH, Karim SA, Kelly C, Maslankowski L, Rees H, Profy AT, Day J, Welch J, Rosenberg Z, HIV Prevention Trials Network (HPTN) 020 Protocol Team.
    AIDS; 2003 Feb 14; 17(3):321-9. PubMed ID: 12556685
    [Abstract] [Full Text] [Related]

  • 80. Acceptability of PRO2000 vaginal gel among HIV un-infected women in Pune, India.
    Joglekar N, Joshi S, Kakde M, Fang G, Cianciola M, Reynolds S, Mehendale S, HIV Prevention Trial Network 047 Protocol Team.
    AIDS Care; 2007 Jul 14; 19(6):817-21. PubMed ID: 17573603
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.